US2015346209A1PendingUtilityA1
Method of labeling sulfenic acid-containing proteins and peptides
Assignee: UNIV WAKE FOREST HEALTH SCIENCESPriority: Sep 13, 2011Filed: Apr 22, 2015Published: Dec 3, 2015
Est. expirySep 13, 2031(~5.1 yrs left)· nominal 20-yr term from priority
G01N 33/58G01N 33/64C07K 1/1077Y10T436/18C07C 69/738C07K 1/13G01N 1/30
44
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of labeling a sulfenic acid (—SOH) group of a cysteine residue in a protein or peptide, comprises contacting said protein or peptide with a beta-ketoester to covalently couple said beta-ketoester to said cysteine residue and form a beta-ketoester-labeled cysteine residue in said protein or peptide.
Claims
exact text as granted — not AI-modifiedThat which is claimed is:
1 . A method of labeling a sulfenic acid (—SOH) group of a cysteine residue in a protein or peptide, comprising:
contacting said protein or peptide with a beta-ketoester to covalently couple said beta-ketoester to said cysteine residue and form a beta-ketoester-labeled cysteine residue in said protein or peptide.
2 . The method of claim 1 , further comprising the step of:
detecting said beta-ketoester-labeled cysteine residue in said protein or peptide.
3 . The method of claim 1 , further comprising the step of coupling a detectable group, or a protein or peptide binding ligand, to said beta-ketoester.
4 . The method of claim 3 , further comprising the step of detecting said detectable group.
5 . The method of claim 1 , further comprising the step of cleaving said beta-ketoester-labeled cysteine residue to produce a 5-isoxazolone-labeled cysteine residue in said protein or peptide.
6 . The method of claim 5 , further comprising the step of detecting said 5-isoxazolone-labeled cysteine residue in said protein or peptide.
7 . The method of claim 1 , wherein said contacting step is carried by contacting said beta-ketoester to a live cell containing said protein or peptide.
8 . The method of claim 1 , wherein said protein or peptide is selected from the group consisting of enzymes, receptors, ion channels, transcription factors, hormones, receptor ligands, and enzyme substrates.
9 . The method of claim 1 , wherein said beta-ketoester is a compound of Formula I:
wherein:
X is H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, cycloalkylalkenyl, cycloalkylalkynyl, heterocyclo, heterocycloalkyl, heterocycloalkenyl, heterocycloalkynyl, aryl, arylalkyl, arylalkenyl, arylalkynyl, heteroaryl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkynyl, alkoxy, halo, mercapto, azido, cyano, formyl, carboxylic acid, hydroxyl, nitro, acyl, aryloxy, alkylthio, amino, alkylamino, arylalkylamino, disubstituted amino, acylamino, acyloxy, ester, amide, sulfoxyl, sulfonyl, sulfonate, sulfonic acid, sulfonamide, urea, alkoxylacylamino, aminoacyloxy, or a detectable group;
Y is a covalent bond or an alkylene group or a linker; and
Z is H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, cycloalkylalkenyl, cycloalkylalkynyl, heterocyclo, heterocycloalkyl, heterocycloalkenyl, heterocycloalkynyl, aryl, arylalkyl, arylalkenyl, arylalkynyl, heteroaryl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkynyl, alkoxy, halo, mercapto, azido, cyano, formyl, carboxylic acid, hydroxyl, nitro, acyl, aryloxy, alkylthio, amino, alkylamino, arylalkylamino, disubstituted amino, acylamino, acyloxy, ester, amide, sulfoxyl, sulfonyl, sulfonate, sulfonic acid, sulfonamide, urea, alkoxylacylamino, and aminoacyloxy, a detectable group, or a reactive group.
10 . A beta-ketoester for use in covalently labeling an oxidized sulfenic acid cysteine residue of a protein or peptide.
11 . The beta-ketoester of claim 10 , wherein said protein or peptide is selected from the group consisting of enzymes, receptors, ion channels, transcription factors, hormones, receptor ligands, and enzyme substrates.
12 . The beta-ketoester of claim 10 , wherein said beta-ketoester is a compound of Formula I:
wherein:
X is H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, cycloalkylalkenyl, cycloalkylalkynyl, heterocyclo, heterocycloalkyl, heterocycloalkenyl, heterocycloalkynyl, aryl, arylalkyl, arylalkenyl, arylalkynyl, heteroaryl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkynyl, alkoxy, halo, mercapto, azido, cyano, formyl, carboxylic acid, hydroxyl, nitro, acyl, aryloxy, alkylthio, amino, alkylamino, arylalkylamino, disubstituted amino, acylamino, acyloxy, ester, amide, sulfoxyl, sulfonyl, sulfonate, sulfonic acid, sulfonamide, urea, alkoxylacylamino, aminoacyloxy, or a detectable group;
Y is a covalent bond or an alkylene group or a linker; and
Z is H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, cycloalkylalkenyl, cycloalkylalkynyl, heterocyclo, heterocycloalkyl, heterocycloalkenyl, heterocycloalkynyl, aryl, arylalkyl, arylalkenyl, arylalkynyl, heteroaryl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkynyl, alkoxy, halo, mercapto, azido, cyano, formyl, carboxylic acid, hydroxyl, nitro, acyl, aryloxy, alkylthio, amino, alkylamino, arylalkylamino, disubstituted amino, acylamino, acyloxy, ester, amide, sulfoxyl, sulfonyl, sulfonate, sulfonic acid, sulfonamide, urea, alkoxylacylamino, and aminoacyloxy, a detectable group, or a reactive group.Join the waitlist — get patent alerts
Track US2015346209A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.